Recovery of recombinant proteins CFP10 and ESAT6 from Escherichia coli inclusion bodies for tuberculosis diagnosis: a statistical optimization approach
Ludmilla Dela Coletta Troiano Araujo, Daniel Ernesto Rodriguez-Fernández, Márcia Wibrantz, Susan Grace Karp, Gilberto Delinski Junior, Emanuel Maltempide Souza, Carlos Ricardo Soccol, Vanete Thomaz-Soccol
Abstract
Tuberculosis (TB) is among the top ten causes of mortality worldwide and has high prevalence in developing countries. The dissemination of efficient and low-cost diagnosis tools able to identify its latent form, e.g. the delayed hypersensitivity reaction, is of great importance to accomplish the target of TB eradication. Recent studies have shown the potential of specific Mycobacterium tuberculosis immunodominant antigens, CFP10 and ESAT6, as substitutes of tuberculin skin test. The purpose of this study was to optimize the recovery and purification of recombinant CFP10 and ESAT6 from Escherichia coli inclusion bodies using central composite design. The production of CFP10 and ESAT6 in bioreactor presented yields of 233 and 121 mg L−1, respectively, after extraction under optimized conditions: biomass concentration of 15 g per 150 mL of sonication buffer, using 12 cycles of disruption and 7 cycles of solubilization, followed by affinity chromatography purification and removal of endotoxins by the micellar method. The identity of the antigens was confirmed by mass spectrometry and their immunoreactivity after recovery and purification was confirmed by Western blot. These results demonstrate the suitability of the preparation methods in the development of a TB diagnosis kit with potential to be diffused in high TB burden countries.
Keywords
References
Bai et al., 2017
X. Bai, Y. Liang, Y. Yang, J. Zhang, X. Wu
A new method of screening for latent tuberculosis infection: Results from army recruits in Beijing in 2014
Immunology Letters, 186 (2017), pp. 28-32, 10.1016/j.imlet.2017.03.014
Bystryak et al., 2015
S. Bystryak, R. Santockyte, A.S. Peshkovsky
Cell disruption of S. cerevisiae by scalable high-intensity ultrasound
Biochemical Engineering Journal, 99 (2015), pp. 99-106, 10.1016/j.bej.2015.03.014
Daneshian et al., 2006
M. Daneshian, A. Guenther, A. Wendel, T. Hartung, S. von Aulock
In vitro pyrogen test for toxic or immunomodulatory drugs
Journal of Immunological Methods, 313 (2006), pp. 169-175, 10.1016/j.jim.2006.04.009
Dela Coletta Troiano Araujo et al., 2019
L. Dela Coletta Troiano Araujo, M. Wibrantz, D.E. Rodríguez-Fernández, S.G. Karp, A.C. Talevi, E. Maltempi de Souza, et al.
Process parameters optimization to produce the recombinant protein CFP10 for the diagnosis of tuberculosis
Protein Expression and Purification, 154 (2019), pp. 118-125, 10.1016/j.pep.2018.09.016
Hemmati et al., 2011
M. Hemmati, A. Seghatoleslam, M. Rasti, S. Ebadat, N. Mosavari, M. Habibagahi, et al.
Expression and purification of recombinant Mycobacterium tuberculosis (TB) antigens, ESAT-6, CFP-10 and ESAT- 6/CFP-10 and their diagnosis potential for detection of TB patients
Iranian Red Crescent Medical Journal, 13 (2011), pp. 556-563
Junker, 2004
B.H. Junker
Scale-up methodologies for Escherichia coli and yeast fermentation processes
Journal of Bioscience and Bioengineering, 97 (2004), pp. 347-364, 10.1016/S1389-1723(04)70218-2
Li et al., 2016a
F. Li, M. Xu, C. Qin, L. Xia, Y. Xiong, X. Xi, et al.
Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis: an open-label, randomized, two-centre phase 2a clinical trial
Clinical Microbiology and Infection, 22 (2016), p. 889, 10.1016/j.cmi.2016.07.015
e9-889.e16
Li et al., 2016b
F. Li, M. Xu, L. Zhou, Y. Xiong, L. Xia, X. Fan, et al.
Safety of recombinant fusion protein ESAT6-CFP10 as a skin test reagent for tuberculosis diagnosis: an open-label, randomized, single-center phase I clinical trial
Clinical and Vaccine Immunology, 23 (2016), pp. 767-773, 10.1128/CVI.00154-16
Li et al., 2017
G. Li, F. Li, H.-M. Zhao, H.-L. Wen, H.-C. Li, C.-L. Li, et al.
Evaluation of a new IFN-γ release assay for rapid diagnosis of active Tuberculosis in a high-incidence setting
Frontiers in Cellular and Infection Microbiology, 7 (2017), 10.3389/fcimb.2017.00117
Liu et al., 1997
S. Liu, R. Tobias, S. McClure, G. Styba, Q. Shi, G. Jackowski
Removal of endotoxin from recombinant protein preparations
Clinical Biochemistry, 30 (1997), pp. 455-463
Lopes et al., 2010
A.M. Lopes, P.O. Magalhães, P.G. Mazzola, C.O. Rangel-Yagui, J.C.M. de Carvalho, T.C.V. Penna, et al.
LPS removal from an E. coli fermentation broth using aqueous two-phase micellar system
Biotechnology Progress, 26 (2010), pp. 1644-1653, 10.1002/btpr.463
Magalhães et al., 2007
P.O. Magalhães, A.M. Lopes, P.G. Mazzola, C. Rangel-Yagui, T.C.V. Penna, A. Pessoa
Methods of endotoxin removal from biological preparations: a review
Journal of Pharmacy and Pharmaceutical Sciences, 10 (2007), pp. 388-404
Mahmoudi et al., 2013
S. Mahmoudi, S. Mamishi, M. Ghazi, R.H. Sadeghi, B. Pourakbari
Cloning, expression and purification of Mycobacterium tuberculosis ESAT-6 and CFP-10 antigens
Iranian Journal of Microbiology, 5 (2013), pp. 374-378
Mahmoudi et al., 2017
S. Mahmoudi, B. Pourakbari, S. Mamishi
Interferon Gamma Release Assay in response to PE35/PPE68 proteins: a promising diagnostic method for diagnosis of latent tuberculosis
European Cytokine Network (2017), pp. 36-40, 10.1684/ecn.2017.0391
Malaghini et al., 2009
M. Malaghini, S.R. Brockelt, M. Burger, A. Kritski, V. Thomaz-Soccol
Molecular characterization of Mycobacterium tuberculosis isolated in the State of Parana in southern Brazil
Tuberculosis, 89 (2009), pp. 101-105, 10.1016/j.tube.2008.07.005
Malaghini et al., 2011
M. Malaghini, V. Thomaz-Soccol, C.M. Probst, M.A. Krieger, H. Preti, A. Kritski, et al.
Recombinant antigen production for assays of intradermoreaction for diagnosis and surveillance of tuberculosis
Journal of Biotechnology, 156 (2011), pp. 56-58, 10.1016/j.jbiotec.2011.07.015
Målen et al., 2010
H. Målen, S. Pathak, T. Søfteland, G.A. de Souza, H.G. Wiker
Definition of novel cell envelope associated proteins in Triton X-114 extracts of Mycobacterium tuberculosis H37Rv
BMC Microbiology, 10 (2010), p. 132, 10.1186/1471-2180-10-132
Pai et al., 2014
M. Pai, C.M. Denkinger, S.V. Kik, M.X. Rangaka, A. Zwerling, O. Oxlade, et al.
Gamma interferon release assays for detection of Mycobacterium tuberculosis infection
Clinical Microbiology Reviews, 27 (2014), pp. 3-20, 10.1128/CMR.00034-13
Poulsen et al., 2010
C. Poulsen, S. Holton, A. Geerlof, M. Wilmanns, Y.-H. Song
Stoichiometric protein complex formation and over-expression using the prokaryotic native operon structure
FEBS Letters, 584 (2010), pp. 669-674, 10.1016/j.febslet.2009.12.057
Raviglione and Sulis, 2016
M. Raviglione, G. Sulis
Tuberculosis 2015: burden, challenges and strategy for control and elimination
Infectious Disease Reports, 8 (2016), 10.4081/idr.2016.6570
Schluger, 2017
N.W. Schluger
Improving the diagnosis of latent TB infection
Chest, 151 (2017), pp. 1207-1208, 10.1016/j.chest.2017.04.161
Refai et al., 2015
A. Refai, M. Haoues, H. Othman, M.R. Barbouche, P. Moua, A. Bondon, et al.
Two distinct conformational states of Mycobacterium tuberculosis virulent factor early secreted antigenic target 6 kDa are behind the discrepancy around its biological functions
FEBS Journal, 282 (2015), pp. 4114-4129, 10.1111/febs.13408
Renshaw et al., 2005
P.S. Renshaw, K.L. Lightbody, V. Veverka, F.W. Muskett, G. Kelly, T.A. Frenkiel, et al.
Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6
The EMBO Journal, 24 (2005), pp. 2491-2498, 10.1038/sj.emboj.7600732
Saraswat et al., 2013
M. Saraswat, L. Musante, A. Ravidá, B. Shortt, B. Byrne, H. Holthofer
Preparative purification of recombinant proteins: current status and future trends
BioMed Research International (2013), pp. 1-18, 10.1155/2013/312709
Scarpellini et al., 2004
P. Scarpellini, S. Tasca, L. Galli, A. Beretta, A. Lazzarin, C. Fortis
Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection
Journal of Clinical Microbiology, 42 (2004), pp. 3469-3474, 10.1128/JCM.42.8.3469-3474.2004
Sharma et al., 2017
S.K. Sharma, R. Vashishtha, L.S. Chauhan, V. Sreenivas, D. Seth
Comparison of TST and IGRA in diagnosis of latent tuberculosis infection in a high TB-burden setting
Plos One, 12 (2017), Article e0169539, 10.1371/journal.pone.0169539
Singh et al., 2015
A. Singh, V. Upadhyay, A.K. Upadhyay, S.M. Singh, A.K. Panda
Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process
Microbial Cell Factories, 14 (2015), 10.1186/s12934-015-0222-8
Teodorowicz et al., 2017
M. Teodorowicz, O. Perdijk, I. Verhoek, C. Govers, H.F.J. Savelkoul, Y. Tang, et al.
Optimized Triton X-114 assisted lipopolysaccharide (LPS) removal method reveals the immunomodulatory effect of food proteins
Plos One, 12 (2017), Article e0173778, 10.1371/journal.pone.0173778
van Ingen et al., 2009
J. van Ingen, R. de Zwaan, R. Dekhuijzen, M. Boeree, D. van Soolingen
Region of difference 1 in nontuberculous Mycobacterium species adds a phylogenetic and taxonomical character
Journal of Bacteriology, 191 (2009), pp. 5865-5867, 10.1128/JB.00683-09
WHO, 2018
WHO - World Health Organization
Global Tuberculosis Report 2018
https://www.who.int/tb/publications/global_report/en/ (2018)
Accessed 15 March 2019
Xin et al., 2013
T. Xin, H. Jia, J. Ding, P. Li, H. Yang, S. Hou, et al.
Assessment of a protein cocktail-based skin test for bovine tuberculosis in a double-blind field test in cattle
Clinical and Vaccine Immunology, 20 (2013), pp. 482-490, 10.1128/CVI.00592-12
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email